Dr Reddy's earmarks capex worth Rs 1,000 cr for 2021-22 on growth outlook The Capex will be around the same numbers as the 2020-21 fiscal, maybe a bit higher if everything goes through, Dr Reddy's Laboratories CEO Erez Israeli said PTI | May 24, 2021 | Updated 13:48 IST Drug major Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal. "The Capex will be around the same numbers, maybe a bit higher if everything goes through," Dr Reddy's Laboratories CEO Erez Israeli said in an analyst call.